These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33340584)

  • 1. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
    Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
    J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion.
    Tsuruya K; Yokoyama K; Mishima Y; Ida K; Araki T; Ieda S; Ohtsuka M; Inagaki Y; Honda A; Kagawa T; Kamiya A
    J Lipid Res; 2024 Sep; 65(9):100616. PubMed ID: 39111549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Novel Missense Mutation in
    Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
    Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
    Weber ND; Odriozola L; Martínez-García J; Ferrer V; Douar A; Bénichou B; González-Aseguinolaza G; Smerdou C
    Nat Commun; 2019 Dec; 10(1):5694. PubMed ID: 31836711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Reichert MC; Lammert F
    Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of progressive familial intrahepatic cholestasis 3. A proteomics study.
    Guerrero L; Carmona-Rodríguez L; Santos FM; Ciordia S; Stark L; Hierro L; Pérez-Montero P; Vicent D; Corrales FJ
    Biofactors; 2024; 50(4):794-809. PubMed ID: 38284625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
    Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
    BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
    Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
    BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
    Weber ND; Martínez-García J; González-Aseguinolaza G
    J Hepatol; 2022 Mar; 76(3):749-751. PubMed ID: 34626730
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of new correctors for traffic-defective ABCB4 variants by a high-content screening approach.
    Lakli M; Dumont J; Vauthier V; Charton J; Crespi V; Banet M; Riahi Y; Ben Saad A; Mareux E; Lapalus M; Gonzales E; Jacquemin E; Di Meo F; Deprez B; Leroux F; Falguières T
    Commun Biol; 2024 Jul; 7(1):898. PubMed ID: 39048674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
    Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
    J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3.
    Poupon R; Barbu V; Chamouard P; Wendum D; Rosmorduc O; Housset C
    Liver Int; 2010 Feb; 30(2):327-31. PubMed ID: 19840255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver diseases related to MDR3 (ABCB4) gene deficiency.
    Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
    Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
    Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
    Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
    Wu Z; Zhang S; Zhang L; Li M
    Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy.
    Siew SM; Cunningham SC; Zhu E; Tay SS; Venuti E; Bolitho C; Alexander IE
    Hepatology; 2019 Dec; 70(6):2047-2061. PubMed ID: 31099022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
    Delaunay JL; Durand-Schneider AM; Delautier D; Rada A; Gautherot J; Jacquemin E; Aït-Slimane T; Maurice M
    Hepatology; 2009 Apr; 49(4):1218-27. PubMed ID: 19185004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults.
    Cao L; Ling X; Yan J; Feng D; Dong Y; Xu Z; Wang F; Zhu S; Gao Y; Cao Z; Zhang M
    Orphanet J Rare Dis; 2024 Apr; 19(1):157. PubMed ID: 38610052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.